文献速递头颈与中枢神经肿瘤

肿瘤与血液B细胞丰度优于现有免疫检查点阻断反应预测特征用于头颈癌

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer.
PubMed 文献 · Ann Oncol · 2024-11-17

该研究汇总11个临床队列共1232例头颈鳞癌样本,评估肿瘤与血液中多种细胞及生物标志物对免疫检查点阻断(ICB)反应的预测价值。肿瘤B细胞浸润是患者生存和ICB反应的强稳健预测因子,优于三级淋巴结构特征及众多T细胞特征;外周血单核细胞(PBMC)B细胞水平与肿瘤B细胞水平强相关,在两个独立临床队列中预测ICB反应的比值比≥7.8。作者认为PBMC B细胞丰度检测可作为临床决策的实用工具。

要点

  • 肿瘤B细胞浸润是头颈鳞癌患者生存和ICB反应的强稳健预测因子。
  • 肿瘤B细胞浸润优于三级淋巴结构特征及众多T细胞特征等现有ICB反应标志物。
  • PBMC B细胞水平与肿瘤B细胞水平强相关,两个独立队列预测ICB反应比值比≥7.8。

核心结论

  • B细胞丰度无论在PBMC还是肿瘤组织中检测,均为头颈鳞癌ICB反应最强预测因子之一。
  • 作者认为通过流式细胞术检测PBMC B细胞丰度可为临床决策提供实用可及的工具。

研究设计与样本

  • 研究汇总并分析大型头颈鳞癌数据集,涵盖11个临床队列共1232例患者样本。
  • 样本覆盖多种疾病亚型、ICB治疗类型、组织来源、数据模态和测量时间点。
  • 研究综合评估肿瘤和血液中多种细胞类型、传统生物标志物及新兴预测因子的预测能力。

主要发现

  • 肿瘤B细胞浸润是患者生存和ICB反应的强稳健预测因子。
  • 肿瘤B细胞浸润优于所有其他现有ICB反应标志物,包括三级淋巴结构特征和众多T细胞特征。
  • B细胞浸润与促进肿瘤清除的热抗肿瘤微环境相关。
  • PBMC B细胞水平与肿瘤B细胞水平强相关,在两个独立临床队列中预测ICB反应的比值比≥7.8。

临床怎么用

  • 作者认为通过流式细胞术检测PBMC B细胞丰度可为临床决策提供实用可及的工具。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunotherapy has improved the outcomes for some patients with head and neck squamous-cell carcinoma (HNSCC). However, the low and variable response rates observed highlight the need for robust response biomarkers to select patients for treatment. PATIENTS AND METHODS: We assembled and analyzed a large HNSCC dataset, encompassing 11 clinical cohorts including 1232 patient samples, spanning a variety of disease subtypes and immune checkpoint blockade (ICB) treatment types, tissue sources, data modalities, and timing of measurements. We conducted a comprehensive evaluation of the predictive power of various cell types, traditional biomarkers, and emerging predictors in both blood and tumor tissues of HNSCC patients. RESULTS: Tumor B-cell infiltration emerged as a strong and robust predictor of both patient survival and ICB response. It outperformed all other established biomarkers of response to ICB, including the tertiary lymphoid structure signature and numerous T-cell-based signatures. B-cell infiltration was associated with a 'hot' antitumor microenvironment that promotes tumor eradication. Furthermore, B-cell levels in peripheral blood mononuclear cells (PBMCs) correlated strongly with tumor B-cell levels and demonstrated high predictive value for ICB response, with high odds ratios (≥7.8) in two independent clinical cohorts. CONCLUSION: B-cell abundance, whether assessed in PBMCs or tumor tissues, is one of the strongest predictors of ICB response in HNSCC. For translation to patient care, measuring B-cell abundance in PBMCs via cytometry offers a practical and accessible tool for clinical decision making.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Chang TG, Spathis A, Schäffer AA, et al. Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer. Ann Oncol. 2024. PMID: 39551185. doi:10.1016/j.annonc.2024.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。